Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Mustang Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Mustang Bio Inc MBIO.OQ reported a quarterly adjusted loss of $37.95 per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-43.00. The lone analyst forecast for the quarter was for a loss of $8.00 per share. Reported revenue was zer...
Reuters
Fri, Mar 28
Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal
By Sneha S K March 28 (Reuters) - Novo Nordisk NOVOb.CO is licensing Lexicon Pharmaceuticals' LXRX.O experimental obesity drug in a deal worth up to $1 billion, the Danish drugmaker's second deal this week, as it looks to strengthen the pipeline of its weight-loss treatments. Under...
Reuters
Fri, Mar 28
Global equity funds saw strong weekly inflows on early optimism, but trade jitters resurface
March 28 (Reuters) - Global equity funds attracted large inflows in the week through March 26 when equity markets initially rebounded on optimism that President Donald Trump's administration would apply tariffs more selectively rather than impose broad trade restrictions.Investors purchased glob...
Reuters
Fri, Mar 28
China's Ecarx slides on $45 mln share sale
** U.S.-listed shares of Chinese auto tech provider Ecarx Holdings ECX.O down 22.6% premarket to $1.75, a seven-week low, after follow-on priced** Co sells 25 mln shares at $1.80 for total deal size of $45 mln** Offering price represents 20.4% discount to stock's last sale on Thurs** Co plans t...
Reuters
Fri, Mar 28
2 Dividend Stocks to Double Up on Right Now
The recent market pullback sent some quality dividend stocks lower, pushing their yields higher in the process. If you're looking to generate some income with the potential for capital appreciation, this could be a good time to increase your exposure to some attractive situations.Realty Income (NYSE...
The Motley Fool
Fri, Mar 28
Prediction: Buying Medtronic Today Will Set You Up for Life
Healthcare can be a complex sector, and it is one that I long ago decided to outsource to the industry professionals who run closed-end fund Blackrock Health Sciences Trust. But I couldn't resist dipping my toe into the sector when I saw the historically high yield on offer from Medtronic (NYSE: MDT...
The Motley Fool
Fri, Mar 28
Better Artificial Intelligence Stock: AMD vs. Nvidia
One of the foundational pieces of the fast-growing artificial intelligence (AI) market has been the advanced semiconductors that make AI tools possible. Nvidia (NASDAQ: NVDA) has garnered the most attention in this space, as its processors dominate AI data centers.But its smaller rival, Advanced Mic...
The Motley Fool
Fri, Mar 28
US STOCKS-Wall St set for lower open after data fans inflation worries
US consumer spending rises in FebruaryUS core inflation firmer in FebruaryBullion miners track higher gold prices Lululemon shares slide after bleak annual outlookFutures off: Dow 0.26%, S&P 500 0.36%, Nasdaq 0.50%By Pranav Kashyap and Johann M Cherian March 28 (Reuters) - Wall Street'...
Reuters
Fri, Mar 28
Rocket Lab shares soar after winning U.S. Space Force national security contract
Investing.com -- The U.S. Space Force's Space Systems Command announced on Thursday that it has awarded contracts to Rocket Lab USA, Inc. (NASDAQ:RKLB) and Stoke Space as part of efforts to broaden it
Investing.com
Fri, Mar 28
1 Wall Street Analyst Thinks Tesla Stock Is Going to $404. Is It a Buy?
Tesla (NASDAQ: TSLA) shares have been on the rebound after a horrible start to the year. There has been a plethora of crosswinds for the company and its shares. One Wall Street analyst now thinks investors have a great opportunity for solid returns from recent levels.Canaccord analyst George Gianari...
The Motley Fool
Fri, Mar 28
NEOS Investments Announces March 2025 ETF Suite Distributions
March 28 (Reuters) - NEOS Enhanced Income Credit Select ETF HYBI.O:NEOS INVESTMENTS ANNOUNCES MARCH 2025 ETF SUITE DISTRIBUTIONS
Reuters
Fri, Mar 28
BofA Securities downgrades Schneider National on tariff uncertainty, demand concer
Investing.com -- Analysts at BofA Securities have downgraded their rating on Schneider National (NYSE:SNDR) to “neutral” from “buy” in a note dated Friday. This decision reflects concerns about softer
Investing.com
Fri, Mar 28
Synergy CHC Corp
expected to post earnings of 10 cents a share - Earnings Preview
Synergy CHC Corp SNYR.OQ SNYR.O is expected to report resultson March 31 for the period ending December 31 2024The Westbrook Maine-based company is expected to report revenue of $323.12 thousand, according to the estimate from one analyst, based on LSEG data.LSEG's mean analyst estimate for Sy...
Reuters
Fri, Mar 28
Is Meta Platforms an Underrated Artificial Intelligence Stock?
Meta Platforms (NASDAQ: META) is a top social media company which routinely generates billions in profit each quarter. But as with any growth-oriented business, it's eyeing the next big opportunity. And right now, its sights appear to be set on artificial intelligence (AI). The company has its own c...
The Motley Fool
Fri, Mar 28
Beam Therapeutics rises after FDA clears genetic disorder drug application
** Biotech firm Beam Therapeutics' BEAM.O shares rise 5.6% to $23.43 premarket** BEAM said late on Thursday that the U.S. FDA has cleared its marketing application for its experimental drug, BEAM-302, to treat a type of genetic disorder called alpha-1 antitrypsin deficiency (AATD)** AATD is a ra...
Reuters
Fri, Mar 28
Oxford Industries tumbles on downbeat annual profit forecast
** Shares of clothing company Oxford Industries OXM.N fall 12.3% to $54.88 premarket ** Co late on Thursday forecast 2025 adj. profit in the range of $4.60/share to $5/share; analysts on average expect 2025 profit of $6.59/share, as per data compiled by LSEG ** OXM expects Q1 net sales between $375...
Reuters
Fri, Mar 28
LIVE MARKETS-Individual investor bears have been on quite a run - AAII
U.S. equity index futures dipUS Feb yoy PCE price index +2.5%(+2.5% est);core +2.8%(+2.7% est)Euro STOXX 600 index off ~0.5%Dollar, gold up; crude flat; bitcoin down >2%U.S. 10-Year Treasury yield falls to ~4.31%Welcome to the home for real-time coverage of markets brought to you by Reuters repor...
Reuters
Fri, Mar 28
NovaGold Resources Inc
expected to post a loss of 4 cents a share - Earnings Preview
NovaGold Resources Inc NG.A, NG is expected to report resultson April 1 for the period ending February 28 2025LSEG's mean analyst estimate for NovaGold Resources Inc is for a loss of 4 cents per share. The current average analyst rating on the shares is "hold" and the breakdown of recom...
Reuters
Fri, Mar 28
Checkpoint Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Checkpoint Therapeutics Inc CKPT.OQ reported a quarterly adjusted loss of 69 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-1.10. The mean expectation of three analysts for the quarter was for a loss of 19 cents per sh...
Reuters
Fri, Mar 28
NYSE Content advisory: Pre-market update + The Ronald Reagan Foundation and Institute rings the Opening Bell
NEW YORK, March 28, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2Yk...
PR Newswire
Fri, Mar 28
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free